146 related articles for article (PubMed ID: 8639245)
1. Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line.
Morelli S; Alama A; Quattrone A; Gong L; Copreni E; Canti G; Nicolin A
Anticancer Drug Des; 1996 Jan; 11(1):1-14. PubMed ID: 8639245
[TBL] [Abstract][Full Text] [Related]
2. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
3. Consequences of the t(14;18) chromosomal translocation in follicular lymphoma: deregulated expression of a chimeric and mutated BCL-2 gene.
Hua C; Zorn S; Jensen JP; Coupland RW; Ko HS; Wright JJ; Bakhshi A
Oncogene Res; 1988 Feb; 2(3):263-75. PubMed ID: 3285301
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.
Smith MR; Abubakr Y; Mohammad R; Xie T; Hamdan M; al-Katib A
Cancer Gene Ther; 1995 Sep; 2(3):207-12. PubMed ID: 8528964
[TBL] [Abstract][Full Text] [Related]
5. Concurrent activation of c-myc and inactivation of bcl-2 by chromosomal translocation in a lymphoblastic lymphoma cell line.
Kiem HP; Nourse J; Saltman DL; Blume KG; Cleary ML
Oncogene; 1990 Dec; 5(12):1815-9. PubMed ID: 2284100
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
Mohammad R; Abubakr Y; Dan M; Aboukameel A; Chow C; Mohamed A; Hamdy N; Al-Katib A
Clin Cancer Res; 2002 Apr; 8(4):1277-83. PubMed ID: 11948143
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model.
Cotter FE; Johnson P; Hall P; Pocock C; al Mahdi N; Cowell JK; Morgan G
Oncogene; 1994 Oct; 9(10):3049-55. PubMed ID: 8084613
[TBL] [Abstract][Full Text] [Related]
8. The role of Bcl-2 protein and autocrine growth factors in a human follicular lymphoma-derived B cell line.
Blagosklonny MV; Neckers LM
Eur Cytokine Netw; 1995; 6(1):21-7. PubMed ID: 7795171
[TBL] [Abstract][Full Text] [Related]
9. Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.
Masir N; Campbell LJ; Jones M; Mason DY
Pathology; 2010 Apr; 42(3):212-6. PubMed ID: 20350212
[TBL] [Abstract][Full Text] [Related]
10. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
11. BCL-2 regulation targeting the AU-rich domain.
Bevilacqua A; Ceriani MC; Schiavone N; Nicolin A
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1273-9. PubMed ID: 11097057
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
[TBL] [Abstract][Full Text] [Related]
13. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
Strasser A; Harris AW; Bath ML; Cory S
Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
Hockenbery D; Nuñez G; Milliman C; Schreiber RD; Korsmeyer SJ
Nature; 1990 Nov; 348(6299):334-6. PubMed ID: 2250705
[TBL] [Abstract][Full Text] [Related]
15. The antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotides.
Morelli S; Delia D; Capaccioli S; Quattrone A; Schiavone N; Bevilacqua A; Tomasini S; Nicolin A
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8150-5. PubMed ID: 9223330
[TBL] [Abstract][Full Text] [Related]
16. Juxtaposition of human bcl-2 and immunoglobulin lambda light chain gene in chronic lymphocytic leukemia is the result of a reciprocal chromosome translocation between chromosome 18 and 22.
Adachi M; Tsujimoto Y
Oncogene; 1989 Sep; 4(9):1073-5. PubMed ID: 2506501
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.
Korsmeyer SJ; Shutter JR; Veis DJ; Merry DE; Oltvai ZN
Semin Cancer Biol; 1993 Dec; 4(6):327-32. PubMed ID: 8142617
[TBL] [Abstract][Full Text] [Related]
18. The bcl-2 oncogene and apoptosis.
Hockenbery DM
Semin Immunol; 1992 Dec; 4(6):413-20. PubMed ID: 1286168
[TBL] [Abstract][Full Text] [Related]
19. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
Soubeyran P; Hostein I; Debled M; Eghbali H; Soubeyran I; Bonichon F; Astier-Gin T; Hoerni B
Br J Cancer; 1999 Nov; 81(5):860-9. PubMed ID: 10555759
[TBL] [Abstract][Full Text] [Related]
20. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
